In addition, the FDA has recommended hourly monitoring of vital signs during the FDO period, with ECGs (electrocardiograms, which measure the electrical activity of the heart) performed both before and after the FDO. Finally, the FDA now mandates more rigorous overnight monitoring of the FDO for individuals with known slowed heart rates or other conditions associated with the slowing of electrical